Ynno Med is a drug R&D platform dedicated to addressing the unmet clinical needs of new antimicrobial agents tackling antimicrobial resistance. Our goal is to design, develop, and distribute first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infections, and suppress the generation of new antimicrobial resistance. We also are able to provide drug design and discovery services by using our AI-assisted drug discovery technologies.
Company Details
- Founded
- 2021
- Address
- Hong Kong, Hk
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.ynnomed.com
- HQ
- Hong Kong
Ynno Med Limited Questions
Ynno Med Limited's website is https://www.ynnomed.com
Ynno Med Limited's LinkedIn profile is https://hk.linkedin.com/company/ynnomed
Ynno Med Limited's industry is
Research Services
Ynno Med Limited's top competitors are
天津盖伦医学科技有限公司,
Kerlyon,
Hwtai Biotec,
Intco Medical,
Spring Test Kits,
Tytek Medical Inc.,
Zhejiang Kindly Medical Devices Co., Ltd,
Pediastent,
Tianck Medical Co.,ltd,
Tonbridge Medical.
Ynno Med Limited's categories are Research Services
Ynno Med Limited's founding year is 2021
